Stay updated on CTL019 in Adult ALL: Efficacy & Safety Clinical Trial

Sign up to get notified when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-05-14T19:48:34.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T06:37:33.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-22T23:54:56.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The page has undergone significant content changes, including the removal of detailed study information regarding the efficacy and safety of CTL019 for adult patients with relapsed and refractory B-cell Acute Lymphoblastic Leukemia, while adding a new version number and a reference to B-cell Acute Lymphoblastic Leukemia.
    Difference
    54%
    Check dated 2025-04-15T20:46:29.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-08T17:13:14.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Difference
    0.7%
    Check dated 2025-04-01T13:29:39.000Z thumbnail image

Stay in the know with updates to CTL019 in Adult ALL: Efficacy & Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CTL019 in Adult ALL: Efficacy & Safety Clinical Trial page.